Powles, T., D. Robinson, J. Stebbing, J. Shamash, M. Nelson, B. Gazzard, S. Mandelia, H. Moller, and M. Bower. 2009. Highly active antiretroviral therapy and the incidence of non-AIDS–defining cancers in people with HIV infection. Journal of Clinical Oncology 27(6):884–890.
Rabkin, C. S., R. J. Biggar, M. S. Baptiste, T. Abe, B. A. Kohler, and P. C. Nasca. 1993. Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. International Journal of Cancer 55(2):208–212.
Shahinian, V., S. Rajaraman, M. Borucki, J. Grady, W. M. Hollander, and T. S. Ahuja. 2000. Prevalence of HIV-associate nephropathy in autopsies of HIV-infected patients. American Journal of Kidney Diseases 35:884–888.
Shiels, M. S., S. R. Cole, G. D. Kirk, and C. Poole. 2009. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. Journal of Acquired Immune Deficiency Syndromes 52(5):611–622.
Smith, C., and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. 2009. Association between modifiable and non-modifiable risk factors and specific causes of death in the HAART era: The data collection on adverse events of anti-HIV drugs study. Paper presented at Conference on Retroviruses and Opportunistic Infections Montreal, Canada, February 8–11.
Soriano, V., M. Sulkowski, C. Bergin, A. Hatzakis, P. Cacoub, C. Katlama, A. Cargnel, S. Mauss, D. Dieterich, S. Moreno, C. Ferrari, T. Poynard, and J. Rockstroh. 2002. Care of patients with chronic hepatitis C and HIV co-infection: Recommendations from the HIV–HCV international panel. AIDS 16(6):813–828.
Sulkowski, M. S. 2004. Hepatitis C virus infection in HIV-infected patients. Current HIV/ AIDS Reports 1(3):128–135.
Szczech, L. A., S. K. Gupta, R. Habash, A. Guasch, R. Kalayjian, R. Appel, T. A. Fields, L. P. Svetkey, K. H. Flanagan, P. E. Klotman, and J. A. Winston. 2004a. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney International 66(3):1145–1152.
Szczech, L. A., D. R. Hoover, J. G. Feldman, M. H. Cohen, S. J. Gange, L. Goozé, N. R. Rubin, M. A. Young, X. Cai, Q. Shi, W. Gao, and K. Anastos. 2004b. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clinical Infectious Diseases 39(8):1199–1206.
Tien, P. C., M. F. Schneider, S. R. Cole, A. M. Levine, M. Cohen, J. Dehovitz, M. Young, and J. E. Justman. 2007. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women’s Interagency HIV Study. AIDS 21(13):1739–1745.
Wilson, S., G. Scullard, S. Fidler, J. Weber, and N. Poulter. 2009. Effects of HIV status and antiretroviral therapy on blood pressure. HIV Medicine 10(6):388–394.
Winston, J., G. Deray, T. Hawkins, L. Szczech, C. Wyatt, and B. Young. 2008. Kidney disease in patients with HIV infection and AIDS. Clinical Infectious Diseases 47(11):1449–1457.
Worm, S. W., C. Sabin, R. Weber, P. Reiss, W. El-Sadr, F. Dabis, S. De Wit, M. Law, A. D. Monforte, N. Friis-Møller, O. Kirk, E. Fontas, I. Weller, A. Phillips, and J. Lundgren. 2010. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: The data collection on adverse events of anti-HIV drugs (D:A:D) study. Journal of Infectious Diseases 201(3):318–330.